Skip to main content

Market Overview

80 Biggest Movers From Yesterday

Share:
80 Biggest Movers From Yesterday

Gainers

  • Cancer Genetics, Inc. (NASDAQ: CGIX) shares climbed 114.8% to close at $6.25 on Monday after the company signed a definitive merger agreement with StemoniX.
  • Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares climbed 48.3% to close at $3.90 after the U.S. FDA issued an emergency use authorization for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients.
  • Tortoise Acquisition Corp. (NASDAQ: SHLL) gained 33.7% to close at $40.00. After its first successful specialty purpose acquisition company, Tortoise Acquisition Corp. is launching a second SPAC. Tortoise Acquisition Corp. will offer 250 million shares at a price of $10 per share, according to a Monday SEC filing.
  • iBio, Inc. (NASDAQ: IBIO) surged 30% to close at $2.21 after falling over 14% on Friday.
  • TravelCenters of America Inc. (NASDAQ: TA) shares surged 29.6% to close at $22.37. BTIG initiated coverage on TravelCenters Of America with a Buy rating and a price target of $34.
  • VivoPower International PLC (NASDAQ: VVPR) shares climbed 25.6% to close at $3.29 after the company reported better-than-expected preliminary results for FY20.
  • AutoWeb, Inc. (NASDAQ: AUTO) gained 24.1% to close at $3.45. AutoWeb, last week, said it sees preliminary July sales at $6.1 million.
  • Nano-X Imaging Ltd. (NASDAQ: NNOX) shares jumped 23% to close at $26.70. Nano-X Imaging shares gained 21% on Friday after pricing its IPO at $18 per share.
  • Blink Charging Co. (NASDAQ: BLNK) gained 18.7% to close at $8.07 in sympathy with the overall market.
  • Orchard Therapeutics plc (NASDAQ: ORTX) rose 18.7% to close at $5.53. Orchard Therapeutics announced clinical data presentations at the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation.
  • Velocity Financial, Inc. (NYSE: VEL) gained 18.6% to close at $6.25. Velocity Financial, earlier during the month, released Q2 results.
  • XpresSpa Group, Inc. (NASDAQ: XSPA) climbed 18.4% to close at $3.22 as the company announced it had cut the waiting time for COVID-19 tests conducted at airports from 48 hours to under 15 minutes.
  • Nabors Industries Ltd. (NYSE: NBR) shares surged 17.8% to close at $39.34.
  • Transocean Ltd. (NYSE: RIG) climbed 17.5% to close at $1.34. Transocean shares dipped over 28% on Friday on bankruptcy concerns.
  • Kamada Ltd. (NASDAQ: KMDA) gained 17.3% to close at $11.73 after the FDA issued an emergency use authorization for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients.
  • Party City Holdco Inc. (NASDAQ: PRTY) surged 16.5% to close at $2.33 after declining 11% on Friday.
  • Groupon, Inc. (NASDAQ: GRPN) gained 16.2% to close at $ 32.58 in sympathy with the overall market.
  • RumbleON, Inc. (NASDAQ: RMBL) jumped 16.1% to close at $32.98. A Form 4 filing filed with the SEC on Monday, August 24 showed that and Chesrown Marshall bought 1,500 shares at an average price of $28.52.
  • Bristow Group Inc. (NASDAQ: VTOL) shares gained 15.3% to close at $ 24.39.
  • Travelzoo (NASDAQ: TZOO) surged 15.3% to close at $7.48.
  • GTT Communications, Inc. (NYSE: GTT) shares rose 14.4% to close at $4.92. GTT, last week, received NYSE notice regarding delayed form 10-Q filing.
  • Meredith Corporation (NYSE: MDP) gained 14.4% to close at $ 14.25.
  • ADMA Biologics, Inc. (NASDAQ: ADMA) shares rose 13.9% to close at $2.87 after the FDA issued emergency use authorization for the use of investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients.
  • Li Auto Inc. (NASDAQ: LI) gained 13.8% to close at $17.09.
  • Brainsway Ltd. (NASDAQ: BWAY) rose 13.4% to close at $7.35 after the company received 501(k) clearance from the FDA for its deep transcranial magnetic stimulation system as an aid in short-term smoking cessation.
  • Synchronoss Technologies, Inc. (NASDAQ: SNCR) gained 13.4% to close at $4.39. Synchronoss Technologies reported better-than-expected Q2 results earlier in the month.
  • Rocket Companies, Inc. (NYSE: RKT) climbed 12.4% to close at $29.11 after surging around 9% on Friday. Rocket Companies is expected to report Q2 results on September 2.
  • LG Display Co., Ltd. (NYSE: LPL) rose 12.3% to close at $6.28.
  • ThermoGenesis Holdings, Inc. (NASDAQ: THMO) gained 11.1% to close at $4.11 after the FDA issued emergency use authorization for the use of investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients.
  • Abraxas Petroleum Corporation (NASDAQ: AXAS) gained 10.8% to close at $0.1956 after Angelo, Gordon & Co. reported a 16.6% active stake in the company.
  • Kelly Services, Inc. (NASDAQ: KELYB) shares gained 10.6% to close at $35.17 after gaining 26% on Friday.
  • Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) shares gained 8.6% to close at $8.20 after surging over 12% on Friday. Catabasis Pharmaceuticals posted a Q2 loss earlier during the month.
  • Velocity Financial, Inc. (NYSE: VEL) shares rose 8.6% to close at $6.25 after jumping 25% on Friday.
  • Liminal BioSciences Inc. (NASDAQ: LMNL) gained 7.1% to close at $13.59 after the FDA issued an emergency use authorization for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients.
  • T2 Biosystems, Inc. (NASDAQ: TTOO) gained 6.9% to close at $1.55 after declining around 6% on Friday. T2 Biosystems, earlier during the month, reported upbeat quarterly results.
  • XBiotech Inc (NASDAQ: XBIT) gained 6.6% to close at $19.57 after the company said the FDA issued an emergency use authorization for COVID-19 Convalescent Plasma as a treatment for COVID-19, which opens the door for its antibody screening technology used to identify CCP.
  • Oblong Inc. (NASDAQ: OBLG) gained 5.4% to close at $2.34 after the company said it secured largest initial mezzanine order in its history.
  • Proteostasis Therapeutics Inc (NYSE: PTI) gained 4.6% to close at $1.36 after the company and Yumanity Therapeutics reported a merger agreement.

Check out these big penny stock gainers and losers

Losers

  • Odonate Therapeutics Inc (NASDAQ: ODT) shares dipped 45.4% to close at $18.33 on Monday after the company announced the results from CONTESSA, a phase 3 study of Tesetaxel.
  • Northern Dynasty Minerals Ltd. (NYSE: NAK) dropped 38.2% to close at $0.8960 in pre-market trading following a WSJ report suggesting the company's gold and copper mine planned for Alaska faces a roadblock by the Trump administration over environmental concerns.
  • FTS International, Inc. (NYSE: FTSI) shares fell 36.5% to close at $3.15. FTS International reported an agreement with majority of its secured debtholders on restructuring support agreement to convert over $400 million of debt to equity.
  • Hexindai Inc. (NASDAQ: HX) shares declined 26.4% to close at $1.90.
  • Tricida, Inc. (NASDAQ: TCDA) shares fell 23.6% to close at $10.11 after the company received a Complete Response Letter from the FDA for its New Drug Application for Veverimer.
  • Trevi Therapeutics, Inc. (NASDAQ: TRVI) shares dropped 21.8% to close at $3.74. Trevi Therapeutics released Q2 results earlier during the month.
  • MOGU Inc. (NYSE: MOGU) fell 20.4% to close at $2.50 after the company reported Q1 results.
  • CHF Solutions, Inc. (NASDAQ: CHFS) dipped 20% to close at $0.3680 after dropping 7% on Friday. CHF Solutions, last week, reported the pricing of $12.5 million offering at $0.45 per unit.
  • NanoViricides, Inc. (NYSE: NNVC) dipped 19.2% to close at $3.92.
  • Sorrento Therapeutics, Inc. (NASDAQ: SRNE) shares fell 19.1% to close at $8.12. Sorrento Therapeutics, last week, announced it has entered into a merger agreement to acquire SmartPharm and develop a pipeline of gene-encoded therapeutic antibodies, starting with neutralizing antibodies to treat Covid-19 and cancer therapeutics.
  • Vir Biotechnology, Inc. (NASDAQ: VIR) dropped 18.8% to close at $42.95. Vir Biotechnology and Harbour BioMed announced plans to collaborate on development and commercialization of novel therapeutic molecules in the field of immuno-oncology and infectious disease.
  • Lifeway Foods, Inc. (NASDAQ: LWAY) dipped 17.7% to close at $4.79.
  • GrowGeneration Corp. (NASDAQ: GRWG) fell 17.3% to close at $14.34. On Friday, Hindenburg published a bearish piece on GrowGeneration.
  • Urban One, Inc. (NASDAQ: UONE) dropped 17.3% to close at $4.15. Urban One, earlier during the month, reported a $25 million at-the-market equity offering program.
  • Immunic, Inc. (NASDAQ: IMUX) dipped 17.1% to close at $15.29.
  • Ovid Therapeutics Inc. (NASDAQ: OVID) fell 16.8% to close at $6.37. Ovid Therapeutics released Q2 results earlier in the month.
  • Kirkland's, Inc. (NASDAQ: KIRK) fell 16.6% to close at $10.18. Kirkland's is expected to release Q2 earnings on September 3.
  • Akers Biosciences, Inc. (NASDAQ: AKER) dipped 16.6% to close at $4.38 after falling 11% on Friday. Akers Biosciences, earlier during the month, announced a 1.207 million share common stock offering at $5.67 per share.
  • Cleveland BioLabs, Inc. (NASDAQ: CBLI) shares fell 16.3% to close at $1.95.
  • Vuzix Corporation (NASDAQ: VUZI) fell 15.8% to close at $3.63. Vuzix shares climbed over 17% on Friday after Rozetta selected the company's Smart Glasses for two separate translation-centric solutions.
  • Co-Diagnostics, Inc. (NASDAQ: CODX) declined 15.4% to close at $12.57. Co-Diagnostics, earlier during the month, reported worse-than-expected Q2 results.
  • Marathon Patent Group, Inc. (NASDAQ: MARA) fell 14.8% to close at $2.31. Marathon Patent Group, earlier in the month, announced it has entered into a long term purchase contract with Bitmain for the purchase of 10,500 next-generation Antminer S-19 Pro ASIC Miners.
  • Westwater Resources, Inc. (NASDAQ: WWR) shares dipped 14.4% to close at $1.84. Westwater Resources posted a Q2 loss of $0.43 per share earlier in the month.
  • Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI) fell 14.2% to close at $0.3950. Hancock Jaffe Laboratories shares climbed 64% on Friday after the company announced two additional VenoValve patients from its first-in-man clinical study in Columbia reached the one-year milestone following VenoValve surgery and chronic venous insufficiency significantly improved in both patients.
  • Yield10 Bioscience Inc (NASDAQ: YTEN) shares fell 14.1% to close at $4.34 after the company announced a common stock offering of 835,000 shares at $4.25 per share.
  • Calyxt, Inc. (NASDAQ: CLXT) dropped 13.4% to close at $4.98 after declining 13% on Friday.
  • Novavax, Inc (NASDAQ: NVAX) fell 13.3% to close at $119.26 after reports suggesting Trump is considering fast-tracking AstraZeneca's coronavirus vaccine candidate, adding to competitive pressures. Meanwhile, Novavax initiated Phase 2 portion of Phase 1/2 clinical trial of coronavirus vaccine.
  • Inovio Pharmaceuticals, Inc. (NASDAQ: INO) dropped 13.2% to close at $12.24 following a report that AstraZeneca’s COVID-19 vaccine maybe fast-tracked for approval in the United States.
  • VBI Vaccines Inc. (NASDAQ: VBIV) shares fell 12.7% to close at $3.1850 after dropping over 6% on Friday. VBI Vaccines, last week, signed a manufacturing deal with Therapure Biomanufacturing for coronavirus vaccine candidates.
  • Jaguar Health, Inc. (NASDAQ: JAGX) fell 12.1% to close at $0.3930 after declining over 10% on Friday. Jaguar Health, last week, issued updates on investigator-initiated trials of crofelemer.
  • AIM ImmunoTech Inc (NYSE: AIM) fell 11.7% to close at $2.12. On Friday, CEO Equels Thomas K. filed a Form 4 with the SEC. The insider bought 10,730 shares at an average price of $2.33.
  • Capitala Finance Corp. (NASDAQ: CPTA) shares fell 11.5% to close at $10.99.
  • Atossa Therapeutics, Inc. (NASDAQ: ATOS) shares fell 10.7% to close at $3.02. Atossa Therapeutics, last week announced that it has enrolled and dosed the first cohort of healthy participants in the Phase 1 clinical study using AT-301, being administered by nasal spray.
  • Vaxart, Inc. (NASDAQ: VXRT) fell 10.5% to close at $7.36.
  • SPAR Group, Inc. (NASDAQ: SGRP) shares fell 10.4% to close at $0.9320 after jumping 20% on Friday. SPAR Group, last week, named Fay DeVriese as new Chief Financial Officer.
  • DarioHealth Corp. (NASDAQ: DRIO) shares tumbled 10.1% to close at $16.73.
  • EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) dropped 9.7% to close at $0.6097. EyePoint Pharmaceuticals secured a new purchase and marketing agreement with Vantage Outsourcing for DEXYCU.
  • Mohawk Group Holdings, Inc. (NYSE: MWK) fell 9.5% to close at $7.95 after the company reported a common stock offering of approximately 3.36 million shares at $7 per share.
  • Midatech Pharma plc (NASDAQ: MTP) fell 7.8% to close at $2.36 after surging 22% on Friday.
  • NN, Inc. (NASDAQ: NNBR) fell 7.7% to close at $5.48 after the company reported the sale of life sciences division for $825 million.
  • Naked Brand Group Limited (NASDAQ: NAKD) fell 7% to close at $0.2851 after declining 11% on Friday. Naked Brand Group, last week, entered into a global amendment with St.George Investments amending convertible promissory note issued by the company.
  • Super League Gaming, Inc. (NASDAQ: SLGG) fell 4.9% to close at $2.14. Super League, on Friday, announced an exclusive recreational esports partnership for its upcoming new game Venture Valley.
 

Related Articles (AIM + ADMA)

View Comments and Join the Discussion!

Posted-In: Movers From YesterdayNews Penny Stocks Pre-Market Outlook Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com